Introduction Insulin resistance may be defined in pharmacological terms as a state in which normal amounts of insulin produce a subnormal biological response [ 1 ]. It is increasingly recognized that the consequences of impaired insulin action are evident in a wide spectrum of clinical disease. In 1988, Gerald Reaven [ 2 ] proposed that tissue resistance to the effects of insulin is a key factor linking glucose intolerance, hypertension, dyslipidaemia and coronary artery disease. This clustering of metabolic abnormalities is termed ‘Syndrome X’, the ‘Metabolic Syndrome’ or the ‘Insulin Resistance Syndrome’. The ‘syndrome’ has been expanded to include other risk factors for cardiovascular disease, including central obesity [ 3 ], abnormalities of thrombosis and fibrinolysis, impaired endothelium‐dependent vasodilatation [ 4 ], and low birthweight [ 5,6 ]. Recently it has been postulated that enhanced activity of the glucocorticoid hormone cortisol contributes to insulin resistance and thus manipulation of cortisol action could provide a novel therapeutic target to enhance insulin sensitivity. In this review, we describe some of the mechanisms whereby glucocorticoids influence insulin sensitivity and the evidence from human studies that glucocorticoids play a key role in the pathophysiology of insulin resistance in the population. Finally, we
Diabetes Obesity & Metabolism – Wiley
Published: Jan 1, 2003
Keywords: ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera